OraSure Technologies to Present at SG Cowen's Health Care Conference

BETHLEHEM, Pa.--(BUSINESS WIRE)--March 3, 2004--OraSure Technologies, Inc. (Nasdaq NM:OSUR) today announced that Mike Gausling, President and Chief Executive Officer, will speak to the investment community at the SG Cowen Health Care Conference in Boston, Massachusetts. The conference will be simultaneously webcast over the Internet.

Mr. Gausling is scheduled to speak on March 10, 2004, at approximately 10:15 am Eastern Time (7:15 am Pacific Time). Interested investors can access the live audio webcast of the presentation by going to OraSure Technologies' web site, www.orasure.com, and clicking on the Investor Info link. A replay of the audio webcast will be available on OraSure Technologies' web site for seven days.

About OraSure Technologies

OraSure Technologies develops, manufactures and markets oral fluid specimen collection devices and tests and other diagnostic products using its proprietary technologies, including immunoassays and other in vitro diagnostic tests and other medical devices. These products are sold in the United States and certain foreign countries to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities.

OraSure Technologies is the leading supplier of oral-fluid collection devices and assays to the life insurance industry and public health markets for the detection of antibodies to HIV-1. In addition, the Company supplies oral-fluid testing solutions for drugs of abuse testing. For more information on the Company, please go to www.orasure.com.

    CONTACT: OraSure Technologies, Inc.
             Ronald H. Spair, 610-882-1820
             Investorinfo@orasure.com
             www.orasure.com

    SOURCE: OraSure Technologies, Inc.